Abstract
Muscle-invasive bladder cancer is an aggressive disease with high risk of progression or death if left untreated. Unlike many other cancers, there has been no significant improvement in survival rates for bladder cancer for three decades. To improve survival and quality of life, a multidisciplinary approach is essential. In this thesis, several aspects of the multidisciplinary management of muscle-invasive bladder cancer were studied, with a focus on neoadjuvant chemotherapy, staging by FDG-PET/CT, and organ-preserving therapies.
Original language | English |
---|---|
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 16 May 2024 |
Publisher | |
Print ISBNs | 978-90-393-7660-7 |
DOIs | |
Publication status | Published - 16 May 2024 |
Keywords
- Muscle-invasive bladder cancer
- bladder cancer
- bladder-preserving treatment
- bladder-preserving therapy
- bladder-sparing treatment
- bladder-sparing therapy
- radical cystectomy